Shilpa Gupta: Vivek Subbiah shares his vision and tumor agnostic drug development in Athens

Shilpa Gupta shared a post on X:

“The amazing Vivek Subbiah shares his phenomenal vision statement and tumor agnostic drug development in Athens.

Tumours don’t follow text books, patients around the world can not wait for access.

Need to break Eroom’s law.”

Source: Shilpa Gupta/X

Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.